DXY (DingXiangYuan)

Chinese physician network and medical data platform for doctors and consumers.

DXY still holds China's largest physician network but has not shipped a public AI product or raised capital since 2020, while rivals move on both fronts.

DXY runs a 25-year-old community of 4 million registered doctors plus a database of pharmaceutical information that hospitals and drug companies pay to access. The hard part to copy used to be the trust from doctors and the years of data it collected, but now ChatGPT-style AI can answer basic health questions and help with drug lookups almost as well, and larger competitors like Ping An Good Doctor and JD Health are already rolling out AI features while DXY has not. The one thing that matters: whether DXY builds and launches a real AI product using its doctor network and proprietary data in the next year, or whether it keeps falling behind while staying silent on new funding.

• 4.05M registered physicians, ~92% of China's doctors (2023)
• $500M Series E led by Trustbridge, Tencent (2020-12)
• No new funding round reported since Dec 2020 (2026-07)

• No new funding or capital event since December 2020 Series E, nearly 6 years as of July 2026. Severity: high
• August 2022 censorship shutdown of 30M+ follower social accounts shows recurring political exposure. Severity: high
• Competitors JD Health and Ping An Good Doctor have shipped visible AI products while DXY has none confirmed. Severity: medium
• Self-reported physician-network figures diverge sharply from independent academic counts, raising data-reliability concerns. Severity: medium

Is DXY (DingXiangYuan) profitable in 2026?

DXY is privately held with no audited public financials. Its last confirmed funding was a $500M Series E in December 2020, and no new capital event has been reported through July 2026, leaving profitability status unconfirmed by any public filing.

Could AI replace DXY's health content and consultation services?

DXY's consumer health articles, symptom triage, and drug-lookup content overlap directly with what GPT-4 class and Chinese LLMs like DeepSeek and Qwen can do. Rivals JD Health and Ping An Good Doctor already shipped AI consultation tools by mid 2024 and 2025, while DXY has no confirmed public AI product as of July 2026.

Who owns DXY and has it had an IPO?

DXY is privately held and VC-backed, with investors including Trustbridge Partners, Tencent Investment, GL Ventures, Shunwei Capital, DCM Ventures, and IDG Capital. No IPO has been confirmed as of July 2026, despite years of Chinese media speculation.

Who is DXY's biggest competitor?

Ping An Good Doctor and JD Health are DXY's most active consumer-side rivals. Ping An reported 400M+ users with an AI-powered consultation system as of July 2025, and JD Health launched an AI mental-health chatbot in May 2024, both areas where DXY has not publicized a comparable AI product.

How many doctors use DXY's platform?

DXY self-reports 4.05 million registered physicians as of 2023, about 92% of China's licensed doctors, while an independent 2023 academic study cited a lower figure of 1.47 million registered doctors, about 71% of the total, showing a gap between company and third-party counts.

Did DXY get censored in China?

Yes. In August 2022, Chinese censors suspended DXY's WeChat, Weibo, and Douyin accounts, which had over 30 million combined followers, after DXY published content questioning the efficacy of the state-promoted TCM remedy Lianhua Qingwen for COVID-19.

• 2025DXY self-reports being named a Hangzhou unicorn for the seventh consecutive year
• 2024-11Tsinghua University unveils Agent Hospital, an AI diagnostic-training platform across 21 specialties
• 2024-05JD Health launches an AI-driven mental-health chatbot
• 2024DXY completes a new Medical Big Data Center and headquarters building in Hangzhou
• 2024DXY runs 130+ free livestream health-education sessions reaching 17M cumulative views
• 2022-08Chinese censors suspend DXY's WeChat, Weibo, and Douyin accounts over TCM remedy criticism
• 2020-12DXY closes $500M Series E led by Trustbridge Partners with Tencent Investment and GL Ventures
• 2018-04DXY raises $100M Series D, reaching unicorn status at roughly $1B valuation
• 2000-07-23DXY founded by Tiantian Li while a student at Harbin Medical University

• DXY.cn
• DXY 2026 Company Profile: Valuation, Funding & Investors
• Dxy.cn Stock Price, Funding, Valuation...
• Chinese online health platform DXY closes $500M raise (2020-10-21)
• Tencent backs Chinese healthcare portal DXY in $500M round (2020-12-28)
• 关于我们_医疗领域的连接者_丁香园生物医药科技网
• DXY Company Profile: Financials, Valuation, and Growth (2024-03-14)
• Research on Influencing Factors of Satisfaction... (2023-01-26)
• China shut down health platform Dingxiangyuan... (2022-08-18)
• China Online Healthcare Market Insights & Forecast Report 2024-2028 (2024-07-01)
• Ping An Good Doctor, WeDoctor... Lead China's Telemedicine Market (2025-07-18)